Skip to main content
EJNMMI Research
Fig. 2 | EJNMMI Research

Fig. 2

From: Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response

Fig. 2

VEGF (top), HGF (middle) and angiopoietin-2 (bottom) levels per time point (baseline, +0, +1, +3, +7 and +30 days post treatment, respectively), for patients with and without response at 1 month post treatment, i.e. partial response and stable disease (n = 32) versus progressive disease (n = 10) of the liver

Back to article page